{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:21:21Z","timestamp":1789176081084,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.urology.2012.03.035","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T15:02:14Z","timestamp":1337785334000},"page":"48-54","source":"Crossref","is-referenced-by-count":36,"title":["Phase IIb, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Determine Effects of Elocalcitol in Women With Overactive Bladder and Idiopathic Detrusor Overactivity"],"prefix":"10.1016","volume":"80","author":[{"given":"G. Alessandro","family":"Digesu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Verdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vik","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Colli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2012.03.035_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"21","author":"Haylen","year":"2010","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.urology.2012.03.035_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2012.03.035_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed?","volume":"87","author":"Milson","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.03.035_bib4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1532-5415.1999.tb01295.x","article-title":"Quality of life impact of urge incontinence in older persons: a new measure and conceptual structure","volume":"47","author":"DuBeau","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urology.2012.03.035_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543784.10.1.65","article-title":"Pharmacological agents for the treatment of urinary incontinence due to overactive bladder","volume":"10","author":"Wein","year":"2001","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.urology.2012.03.035_bib6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.juro.2009.11.026","article-title":"Overactive bladder medication adherence when medication is free to patients","volume":"183","author":"Sears","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2012.03.035_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.2011.554399","article-title":"The medical treatment of overactive bladder, including current and future treatments","volume":"12","author":"Athanasopoulos","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.urology.2012.03.035_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.18553\/jmcp.2008.14.3.291","article-title":"Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan","volume":"14","author":"D'Souza","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.urology.2012.03.035_bib9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/nau.20475","article-title":"Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract","volume":"26","author":"Christ","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2012.03.035_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.tips.2006.07.002","article-title":"Rho kinase: a target for treating urinary bladder dysfunction?","volume":"27","author":"Peters","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.urology.2012.03.035_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1469-7793.2000.t01-2-00177.x","article-title":"Signal transduction by G-proteins, rhokinase and protein phosphatase to smooth muscle and non-muscle myosin II","volume":"522","author":"Somlyo","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.urology.2012.03.035_bib12","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1074\/jbc.M109839200","article-title":"Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies","volume":"277","author":"Chen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urology.2012.03.035_bib13","doi-asserted-by":"crossref","first-page":"23441","DOI":"10.1074\/jbc.M201597200","article-title":"Smooth muscle myosin phosphatase-associated kinase induces Ca2+ sensitization via myosin phosphatase inhibition","volume":"277","author":"Borman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urology.2012.03.035_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.bjp.0704241","article-title":"Dependency of detrusor contractions on calcium sensitization and calcium entry through LOE-908-sensitive channels","volume":"134","author":"Jezior","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.urology.2012.03.035_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/pr.56.4.4","article-title":"Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence","volume":"56","author":"Andersson","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.urology.2012.03.035_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bjp.0705109","article-title":"Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle","volume":"138","author":"Wibberley","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.urology.2012.03.035_bib17","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/jpet.103.063735","article-title":"Signal transduction underlying carbachol-induced contraction of human urinary bladder","volume":"309","author":"Schneider","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.urology.2012.03.035_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.bjp.0706723","article-title":"Involvement of Rho kinase and protein kinase C in carbachol-induced calcium sensitization in beta-escin skinned rat and guinea-pig bladders","volume":"148","author":"Durlu-Kandilci","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.urology.2012.03.035_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.ju.0000130419.32165.6b","article-title":"Ca2+ sensitization in contraction of human bladder smooth muscle","volume":"172","author":"Takahashi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2012.03.035_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1464-410X.2006.06342.x","article-title":"Effects of a vitamin D(3) analogue in a rat model of bladder outlet obstruction","volume":"98","author":"Schroeder","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.03.035_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1210\/jc.2004-1496","article-title":"Human bladder as a novel target for vitamin D receptor ligands","volume":"90","author":"Crescioli","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2012.03.035_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pros.20463","article-title":"BXL628, a vitamin D receptor agonists effective in benign prostatic hyperplasia, prevents RhoA activation and inhibits RhoA\/Rho kinase signaling in rat and human bladder","volume":"67","author":"Morelli","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2012.03.035_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1525-139X.2002.00086.x","article-title":"Comparative review of the pharmacokinetics of vitamin D analogues","volume":"15","author":"Bailie","year":"2002","journal-title":"Semin Dial"},{"key":"10.1016\/j.urology.2012.03.035_bib24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1471-0528.2003.02081.x","article-title":"Reproducibility and reliability of pressure flow parameters in women","volume":"110","author":"Digesu","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.urology.2012.03.035_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1464-410x.1998.00501.x","article-title":"Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study","volume":"81","author":"Rentzhog","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2012.03.035_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02201987","article-title":"Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation","volume":"15","author":"Jonas","year":"1997","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2012.03.035_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/nau.10099","article-title":"overactive bladder symptoms: do we need urodynamics?","volume":"22","author":"Digesu","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2012.03.035_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/(SICI)1097-4644(19961215)63:4<500::AID-JCB11>3.0.CO;2-H","article-title":"Vitamin D analog 25-(OH)-16,23E-Diene-26,27-hexafluoro-vitamin D3 induces differentiation of HL60 cells with minimal effects on cellular calcium homeostasis","volume":"63","author":"Gardner","year":"1996","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.urology.2012.03.035_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2005.08.014","article-title":"BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial","volume":"49","author":"Colli","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.03.035_bib30","doi-asserted-by":"crossref","unstructured":"Streng T, Andersson KE, Hedlund P, et al. Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction. BJU Int. Epub 2012 Jan 30.","DOI":"10.1111\/j.1464-410X.2011.10838.x"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512003743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512003743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T04:12:04Z","timestamp":1642306324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429512003743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0090429512003743"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2012.03.035","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}